NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Finnrick
Free Test
← Tirzepatide vendors

Tianjin Eleli Technology DevelopmentTirzepatide

7 testslatest 18 Sept 2026$0.38/mg median
Message on WhatsApp+85297215245Intelligence report21 pages · who runs this vendorMonitor this vendor24/7 safety alerts · Finnrick Gold
Free peptide testing

Ordered Tirzepatide from Tianjin Eleli Technology Development? Mail in a sample (US only) and let us test it for free.

Test my supply
+4 more ↓
63%
Finnrick rating
#254 of 262 Tirzepatide vendors
2 of 7 classifiable tests passed
natural 29% · customers 3.9★ (11)
methodology · Purity focus
Finnrick analysis · Tirzepatide

Tianjin Eleli's tirzepatide profile is driven down by repeated purity misses plus one severe identity/quantity failure. Check the 0%/0 mg Jan result and the Mar vial at 99.19% purity with +49% overfill.

methodology →
vendor intelligence report
Vendor Intelligence Report: Tianjin Eleli Technology Development

Source code, product-origin fields and a hidden mail target point beyond the Tianjin storefront to a second operator. The report traces the claimed address, young domain, offshore contact rails, dead Discord invites and unsupported FDA/warehouse claims.

21 pages8 risk factors assessed3 Jul 2026
read the report
Peptides
12 rated · tap to focus
#
Peptide
$/MG
Rating
N
1
Retatrutide
$0.87
76%
16
2
GHK-Cu
$0.07
73%
6
3
Tirzepatideselected
$0.38
63%
7
4
BPC-157
$0.75
53%
6
5
Cagrilintide
$2.16
52%
1
6
Tesamorelin
$1.81
47%
4
7
TB-500
$1.65
36%
3
8
GLOW
-
-
0
9
Ipamorelin
$1.24
-
0
10
Melanotan II
$0.45
-
0
11
NAD+
$0.01
-
0
12
PT-141
$0.56
-
0
Contact channels
9 channels on file
WhatsApp+85297215245WhatsApp+85244605704WhatsApp+85244616473WhatsApp+85269003235WhatsApp+8613996213753WhatsApp+8615869024012WhatsApp+8615026552709Websiteailailicn.comEmailailaili20120912@gmail.com
Rating trend
Tirzepatide from this vendor, after each test
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%29 Jan 2026: 77%11 Feb 2026: 77%4 Mar 2026: 71%4 Mar 2026: 67%26 Jun 2026: 66%9 Aug 2026: 62%18 Sep 2026: 63%29 Sep 2026: current 63%77%66%63%Jan 26Sep 26
Showing Tirzepatide tests only
Tianjin Eleli Technology Development Tirzepatide test history
7 tests · 2 pass · 5 fail
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
18 Sep 2026Pass
3t968ga
Tested
lab nameView COA
9 Aug 2026Fail
3vfrd82
Tested
lab nameView COA
26 Jun 2026Fail
kxew8cx
Tested
lab nameView COA
4 Mar 2026Fail
mn943qx
Tested
lab nameView COA
4 Mar 2026Fail
5nveym7
Tested
lab nameView COA
11 Feb 2026Pass
cj9nkd7
Tested
lab nameView COA
29 Jan 2026Fail
y5me3rw
Tested
lab nameView COA

About Tianjin Eleli Technology Development test results from Finnrick

Tianjin Eleli Technology Development is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 7 peptides and 43 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Tianjin Eleli Technology Development peptides in this dataset are BPC-157 (6 tests), Cagrilintide (1 test) and GHK-Cu (6 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 43 recent tests.

Corrections
0 corrections
No corrections.
Free peptide testing

Ordered Tirzepatide from Tianjin Eleli Technology Development? Mail in a sample (US only) and let us test it for free.

Test my supply